HK1007335A1 - Production of insulin-like growth factor binding protein - Google Patents

Production of insulin-like growth factor binding protein

Info

Publication number
HK1007335A1
HK1007335A1 HK98106562A HK98106562A HK1007335A1 HK 1007335 A1 HK1007335 A1 HK 1007335A1 HK 98106562 A HK98106562 A HK 98106562A HK 98106562 A HK98106562 A HK 98106562A HK 1007335 A1 HK1007335 A1 HK 1007335A1
Authority
HK
Hong Kong
Prior art keywords
insulin
growth factor
binding protein
factor binding
production
Prior art date
Application number
HK98106562A
Other languages
English (en)
Inventor
William I Wood
Robert C Baxter
Original Assignee
Genentech Inc
Cent Sydney Area Health Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22624500&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1007335(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc, Cent Sydney Area Health Serv filed Critical Genentech Inc
Publication of HK1007335A1 publication Critical patent/HK1007335A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HK98106562A 1988-03-22 1998-06-25 Production of insulin-like growth factor binding protein HK1007335A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/171,623 US5258287A (en) 1988-03-22 1988-03-22 DNA encoding and methods of production of insulin-like growth factor binding protein BP53
PCT/US1989/000983 WO1989009268A1 (en) 1988-03-22 1989-03-10 Production of insulin-like growth factor binding protein

Publications (1)

Publication Number Publication Date
HK1007335A1 true HK1007335A1 (en) 1999-04-09

Family

ID=22624500

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106562A HK1007335A1 (en) 1988-03-22 1998-06-25 Production of insulin-like growth factor binding protein

Country Status (9)

Country Link
US (2) US5258287A (xx)
EP (1) EP0406272B2 (xx)
JP (2) JP3577311B2 (xx)
AT (1) ATE107958T1 (xx)
CA (1) CA1340703C (xx)
DE (1) DE68916537T3 (xx)
HK (1) HK1007335A1 (xx)
NZ (1) NZ228350A (xx)
WO (1) WO1989009268A1 (xx)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2687995B2 (ja) 1980-04-03 1997-12-08 バイオゲン インコーポレイテッド Ｄｎａ配列、組替えｄｎａ分子およびヒト繊維芽細胞インターフェロン様ポリペプチドの製造方法
US5200509A (en) * 1987-04-06 1993-04-06 Celtrix Pharmaceuticals, Inc. Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
US5693760A (en) * 1988-04-14 1997-12-02 Incyte Pharmaceuticals, Inc. Method of causing selective immunosuppression using HL-60 related lectins
US5633148A (en) * 1988-04-14 1997-05-27 Incyte Pharmaceuticals, Inc. Unique lectins
WO1990000569A1 (en) * 1988-07-15 1990-01-25 Central Sydney Area Health Service Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
US6465423B1 (en) * 1988-07-15 2002-10-15 Central Sydney Area Health Service Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
IL92816A0 (en) * 1988-12-22 1990-09-17 Biogrowth Inc Recombinant dna molecules,hosts,processes and human somatomedin carrier protein-like polypeptides
SE8904361D0 (sv) * 1989-12-22 1989-12-22 Astra Ab New chroman and thiochroman derivatives
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
EP0546081A4 (en) * 1990-08-28 1994-08-17 Chiron Corp New insulin-like growth factor binding protein (igfbp-4)
US5212074A (en) * 1990-08-28 1993-05-18 Chiron Corporation Genetic material encoding new insulin-like growth factor binding protein igfbp-6
US6967080B1 (en) * 1990-12-05 2005-11-22 Novozymes A/S Proteins with changed epitopes and methods for the production thereof
US20050209121A1 (en) * 1990-12-05 2005-09-22 Novozymes A/S Proteins with changed epitopes and methods for the production thereof
FI86777C (fi) * 1990-12-31 1992-10-12 Medix Biochemica Ab Oy Foerfarande foer diagnosticering av bristningen av fosterhinnorna samt reagensfoerpackning foer anvaendning daervid
DE69233155T2 (de) 1991-01-08 2004-06-03 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Insulinartigen wachstumsfaktor bindendes protein
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
FI94181C (fi) 1992-06-29 1995-07-25 Medix Biochemica Ab Oy Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
EP0668879B1 (en) 1992-11-04 2003-06-25 Chiron Corporation Truncated insulin-like growth factor binding proteins having mitogenic activity
AU5608594A (en) * 1992-11-16 1994-06-08 Incyte Pharmaceuticals, Inc. Method of causing selective immunosuppression using hl-60-related lectins
US6406679B1 (en) 1992-11-16 2002-06-18 Incyte Pharmaceuticals, Inc. Use of HL-60-related lectins in drug delivery and detection of lectin-expressing cells
EP0626448A3 (de) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
US5585237A (en) * 1993-10-25 1996-12-17 Creative Biomolecules, Inc. Methods and compositions for high protein production from recombinant DNA
EP0729361A4 (en) * 1993-11-15 1996-11-06 Celtrix Pharma METHOD FOR TREATING NEUROLOGICAL DISEASES
CN1129944A (zh) * 1994-06-27 1996-08-28 雪印乳业株式会社 新型蛋白质及其制备方法
US5789547A (en) * 1995-06-07 1998-08-04 Celtrix Pharmaceuticals, Inc. Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding
US5985830A (en) * 1996-09-16 1999-11-16 Dalhousie University Use of IGF-I for the treatment of kidney disorders
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US5914390A (en) * 1997-05-12 1999-06-22 Celtrix Pharmaceuticals, Inc. Methods for increasing yields of recombinant proteins
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
US6342220B1 (en) 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
US6417330B1 (en) * 1998-06-01 2002-07-09 Celtrix Pharmaceuticals, Inc. Insulin-like growth factor binding protein variants
PT1141014E (pt) 1999-01-06 2005-04-29 Genentech Inc Variante mutante do factor de crescimento semelhante a insulina (igf-i)
JP2002535967A (ja) 1999-01-06 2002-10-29 ジェネンテック・インコーポレーテッド インシュリン様成長因子（ｉｇｆ）ｉ変異体
AU2001263215A1 (en) 2000-05-16 2001-11-26 Genentech Inc. Method for treating cartilage disorders
CA2422625A1 (en) * 2000-09-19 2002-03-28 Bioexpertise, Llc Method for use of igf-binding protein for selective sensitization of target cells in vivo
US7071300B2 (en) 2001-03-14 2006-07-04 Genentech, Inc. IGF antagonist peptides
WO2003039232A2 (en) * 2001-10-26 2003-05-15 Large Scale Biology Corporation Endothelial cell derived hemotopoietic growth factor
CN1870893A (zh) 2003-09-12 2006-11-29 特西卡股份有限公司 胰岛素样生长因子－1(igf－1)缺陷的治疗方法
AU2004278311A1 (en) * 2003-10-03 2005-04-14 Genentech, Inc. IGF binding proteins
JP2006258673A (ja) * 2005-03-18 2006-09-28 Fisheries Research Agency 魚類のｉｇｆ−ｉ濃度の測定方法及びその方法に用いる測定キット
WO2010146059A2 (en) 2009-06-16 2010-12-23 F. Hoffmann-La Roche Ag Biomarkers for igf-1r inhibitor therapy
US9687591B2 (en) 2010-03-31 2017-06-27 Agency For Science, Technology And Research Building stratified biomimetic tissues and organs using crosslinked ultrashort peptide hydrogel membranes
US8999916B2 (en) 2010-03-31 2015-04-07 Agency For Science, Technology And Research Crosslinked peptide hydrogels
KR101895245B1 (ko) 2010-03-31 2018-09-05 에이전시 포 사이언스, 테크놀로지 앤드 리서치 양친매성 선형 펩티드/펩토이드 및 이를 포함하는 히드로겔
US9120841B2 (en) 2012-09-28 2015-09-01 Agency For Science, Technology And Research Amphiphilic linear peptidepeptoid and hydrogel comprising the same
WO2018145048A1 (en) * 2017-02-06 2018-08-09 Academia Sinica Recombinant proteins and uses thereof
MX2020002744A (es) 2017-09-11 2020-10-01 Takeda Pharmaceuticals Co Metodos y composiciones para tratar enfermedades pulmonares cronicas.
KR20230113287A (ko) 2020-10-19 2023-07-28 오크 힐 바이오 리미티드 신생아에 사용하기에 적합한 조성물
WO2023139115A1 (en) 2022-01-19 2023-07-27 Oak Hill Bio Limited Compositions and methods for reducing oxidation of igf‐1/igfbp
WO2023242439A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Vascular stabilisation (preterm infants)
WO2023242442A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Method of maturing/differentiating neurons and/or modulating the vagus nerve
WO2023242440A1 (en) 2022-06-17 2023-12-21 Oak Hill Bio Limited Treament of lungs in infants

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
US4853330A (en) * 1983-04-07 1989-08-01 Genentech, Inc. Human tissue plasminogen activator
US5010002A (en) * 1983-01-19 1991-04-23 Genentech, Inc. Human t-PA production using vectors coding DHFR protein
US5028531A (en) * 1984-03-19 1991-07-02 Fujisawa Pharmaceutical Company, Ltd. IGF-I fusion proteins; protection of IGF-I from degradation by host cell; and processes for the production thereof
US4879231A (en) * 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US5089396A (en) * 1985-10-03 1992-02-18 Genentech, Inc. Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid
US4963665A (en) * 1986-01-07 1990-10-16 Washington University Human preproinsulin-like growth factor I
US4868113A (en) * 1986-03-03 1989-09-19 Rorer Biotechnology, Inc. Recombinant DNA vector encoding human endothelial cell growth factor
GB8610600D0 (en) * 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US5200509A (en) * 1987-04-06 1993-04-06 Celtrix Pharmaceuticals, Inc. Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
ATE90690T1 (de) * 1987-04-06 1993-07-15 Celtrix Pharma Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung.
EP0321196A3 (en) * 1987-12-18 1990-07-18 Mycogen Plant Science, Inc. 780 t-dna gene transcription activator
DK131988A (da) * 1988-03-11 1989-09-12 Erasmus University Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur
EP0418230B1 (en) * 1988-04-12 1995-12-27 Amgen Boulder Inc. Method for potentiating and inhibiting insulin-like growth factor activity
GB8826451D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Improvements in/relating to organic compounds
IL92816A0 (en) * 1988-12-22 1990-09-17 Biogrowth Inc Recombinant dna molecules,hosts,processes and human somatomedin carrier protein-like polypeptides
US5098833A (en) * 1989-02-23 1992-03-24 Genentech, Inc. DNA sequence encoding a functional domain of a lymphocyte homing receptor

Also Published As

Publication number Publication date
US5328891A (en) 1994-07-12
US5258287A (en) 1993-11-02
JP3577311B2 (ja) 2004-10-13
EP0406272B2 (en) 2002-07-24
CA1340703C (en) 1999-08-10
EP0406272B1 (en) 1994-06-29
AU629820B2 (en) 1992-10-15
NZ228350A (en) 1992-03-26
DE68916537T2 (de) 1995-01-19
DE68916537D1 (de) 1994-08-04
JP3985015B2 (ja) 2007-10-03
JPH03505397A (ja) 1991-11-28
JP2004256541A (ja) 2004-09-16
EP0406272A1 (en) 1991-01-09
WO1989009268A1 (en) 1989-10-05
ATE107958T1 (de) 1994-07-15
AU3217889A (en) 1989-10-16
DE68916537T3 (de) 2003-11-27

Similar Documents

Publication Publication Date Title
HK1007335A1 (en) Production of insulin-like growth factor binding protein
HU895836D0 (en) Process for the preparation of carrier proteins
DE69021263D1 (de) Fibronektinbindungsprotein und dessen Herstellung.
GB9108652D0 (en) Immunoreactive compounds
DE3882593D1 (de) Polypeptid und dessen herstellung.
EP0089676A3 (en) Novel dna and use thereof
AU7371587A (en) Peptides that inhibit binding of Von Willebrand factor binding
ES8507473A1 (es) Un procedimiento para preparar un peptido de resina
EP0115397A3 (en) Mica-resin composite material
DE3853446T2 (de) Fibronectinbindungsprotein und dessen Herstellung.
IE801912L (en) Gaming machine
EP0319315A3 (en) The von willebrand factor binding domain of factor viii
EP0643133A3 (de) Rekombinante D-Hydantoinase, Verfahren zur Herstellung und Verwendung.
EP0315118A3 (en) Dna coding for endothelin and use thereof
AR245278A1 (es) Una valvula reguladora de diafragma compensadora de caida de presion de gas.
ATE46537T1 (de) Promotor und dessen verwendung.
EP0264074A3 (en) Expression vector for insulin-like growth factor i
NZ228568A (en) Regulating gene expression with a heterodimer complex of two unlike proteins
EP0343577A3 (en) Des-17-histidine calcitonin
AU1264688A (en) Process for the preparation of factor viii:c-deficient plasma, and a deficient plasma obtained in this way
EP0322084A3 (en) Tumor cell inhibition factor
ES8707706A1 (es) Un procedimiento para la preparacion de nuevos derivados de propanodiona.
EP0327360A3 (en) Novel polypeptides and dna encoding said polypeptides
EP0446361A4 (en) Polypeptide, production thereof, and pharmaceutical composition and cosmetic containing said polypeptide
WO1997025421A3 (en) PROTEIN INDUCED BY DEPRENYL$m(3)

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20090309